2017 is off to a great start for us all at XenoGesis. The recently opened, state-of-the-art bioanalysis and metabolic identification suite is up and running, and our attention is now focused on finding someone to spearhead our business development, more on that later in the newsletter.
Our 2017 events schedule is already looking busy. This month we have been to BioEurope Spring in Barcelona and then Copenhagen for the Medicon Valley Alliance event on drug formulation and bioavailability. We have another webinar planned in May with our friends at Juniper Pharma Services, more details to follow nearer the time.
In a move to further develop our expertise and knowledge of the impact that potential new medicines can have in man from a toxicity point of view, XenoGesis has joined the British Toxicology Society and will be attending the BTS Annual Congress in Liverpool on the 3rd - 5th April. You can read more about this here.
We are also delighted to have been shortlisted as a Medilink UK Business Awards finalist for the Outstanding Achievement category. The awards ceremony takes place next month at the Med-Tech Innovation EXPO in Coventry.
And finally, a huge well done to Graham Trevitt (XenoGesis' answer to Michael Phelps) who raised over £500 for Comic Relief by swimming the distance of the English Channel! It isn't too late to show your support and make a donation.
As always, we welcome your feedback.
Richard Weaver and the team at XenoGesis